Rift is a telehealth technology platform that connects patients with independent, state-licensed healthcare providers and regulated US compounding pharmacies for GLP-1 weight loss treatments
Commonly reported issues include mild gastrointestinal discomfort, particularly when starting the compound, and temporary headaches during the adjustment period
In the 2021 Nature Metabolism study, mice treated with 5-Amino-1MQ showed 35% reduction in white adipose tissue mass without caloric restriction, alongside improved insulin sensitivity and reduced hepatic steatosis
The outer thigh and back of the upper arm are also appropriate
Ethics declarations Competing interests SJW is the founder of Ridgeline Therapeutics, HN is a paid employee of Ridgeline Therapeutics and, since manuscript submission, ADW has also become a paid employee of Ridgeline Therapeutics
Introduction Can 5-Amino-1MQ actually help reduce body fat? 5-Amino-1MQ is an investigational small-molecule compound that inhibits the enzyme nicotinamide N-methyltransferase (NNMT)